Bendroza 2.5 mg/573 mg film-coated tablets

Bendroza is a prescription pharmaceutical product used primarily for the treatment of hypertension (high blood pressure) and edema. It is a combination medication containing bendroflumethiazide, a thiazide diuretic, and potassium chloride to prevent potassium depletion.

The brand is owned and distributed by Orifarm, a major pharmaceutical company headquartered in Denmark. Orifarm is a leading parallel importer of pharmaceuticals in Europe and also develops its own generic products. While the company is Danish, the manufacturing of generic ingredients and the tableting process often occur across multiple international locations within the global pharmaceutical supply chain.

Orifarm remains an independent, family-owned company, making it one of the largest Danish-controlled players in the healthcare sector. It serves various European markets including Scandinavia and Germany.